Financials
- Market Capitalization 335.77 M
- Employee 128
- Founded 2003
- CEO N/A
- Website www.sutrobio.com
- Headquarter California, United States
- FIGI BBG000R4V3P3
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-0.51
売上高対価格比率
0.96
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 3227 | SABS SAB Biotherapeutics, Inc. - Common Stock | 3.70 USD | -2.12% | -1.60% | +4.82% | +75.36% | 336.65 M USD | ||
| 3228 | IMRX Immuneering Corporation - Class A Common Stock | 5.21 USD | -1.70% | +2.36% | +18.95% | +8.54% | 337.07 M USD | ||
| 3240 | YDES YD Bio Limited - Ordinary Shares | 4.77 USD | +1.71% | +48.14% | +115.84% | -40.38% | 337.66 M USD | ||
| 3254 | OBIO Orchestra BioMed Holdings, Inc. - Ordinary Shares | 5.46 USD | +1.87% | +20.53% | +43.68% | +114.12% | 328.17 M USD |